Safe Orthopaedics S.A.
ALSAF.PA · PAR
6/30/2024 | 12/31/2023 | 6/30/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 0.00 | 2.14 |
| FCF Yield | -1,138.15% | -16.06% | -1.74% | -0.53% |
| EV / EBITDA | 2.87 | -1.01 | 0.00 | -231.09 |
| Quality | ||||
| ROIC | -4.62% | -11.59% | 0.00% | -30.37% |
| Gross Margin | -1.65% | 48.74% | 100.00% | -57.96% |
| Cash Conversion Ratio | 0.01 | 0.01 | 0.01 | 0.92 |
| Growth | ||||
| Revenue 3-Year CAGR | 21.52% | 35.39% | 76.28% | 1,065.35% |
| Free Cash Flow Growth | -104.36% | 0.00% | 80.05% | 19.07% |
| Safety | ||||
| Net Debt / EBITDA | 2.87 | -1.00 | 0.00 | -3.87 |
| Interest Coverage | -0.01 | -49.94 | 0.00 | 48.14 |
| Efficiency | ||||
| Inventory Turnover | 0.64 | 0.35 | 0.00 | 1.09 |
| Cash Conversion Cycle | 124.90 | 200.66 | 0.00 | 141.27 |